B

케이엠제약

225430KOSDAQ

61.8 / 100

Reference Date: 2026-09-08

Financial Score19.5 / 40
News Sentiment21.3 / 25
Momentum9.0 / 20
Disclosure12.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 48.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

KEM Pharmaceuticals specializes in oral care, beauty care, and daily necessities, offering a wide range of products such as children's and adult toothpaste, shampoo, body wash, and anti-wrinkle skincare. Its flagship brands, 'Pororo Friends' and 'Kkoma Bus Taeyo,' account for approximately 33.4% of sales, with active OEM/ODM business. The company aims to expand its domestic and international distribution channels and grow into a comprehensive daily necessities company by maintaining high-quality products.

Number of Employees

63people

Average Salary

42.8M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 15.004.0Point
PBR
0.21Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
-13.04Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
22.04Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20250.5 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼4.0% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼74.7% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -10.0% (declining, 3yr)

Detailed News Sentiment

5 totalPositive 5Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position3.0Point

52w lower range (21%)

Current 923Won52-week high 3,03552-week low 340
1-month return0.0Point

1m -48.35% (strong drop)

Volume trend6.0Point

Volume surge

Detailed Disclosure

4 totalPositive 1Neutral 3Negative 0
  • Neutral기타시장안내 (시가총액 미달에 따른 상장폐지 우려 관련 안내)2026-09-07
  • Neutral기타시장안내 (시가총액 미달에 따른 상장폐지 우려 관련 안내)2026-08-31
  • Positive자기주식취득결과보고서2026-08-28
  • Neutral반기보고서 (2026.06)2026-08-14